Volume 1, Issue 3
-
A New Possible Class of Drugs for the Treatment of Schizophrenia
Author(s): Robert R. Conley,
-
The Use of the Theory of Planned Behavior to Predict Medication Adherence in Schizophrenia
Author(s): Alex Kopelowicz, Charles J. Wallace, Robert Paul Liberman,Fabian Aguirre , Roberto Zarate, Jim Mintz
-
A Brief Review of a Brain Model for Schizophrenia and Other Psychotic Disorders Which Might Suggest Novel Treatment Modalities
Author(s): Arash Javanbakht
-
All Psychosis is Not Schizophrenia, Especially Not in Women
Author(s): Mary V. Seeman
-
Psychosis Induced by the Interaction of Memantine and Amantadine: Lending Evidence to the Glutamatergic Theory of Schizophrenia
Author(s): David R. Spiegel, Michael R. Leader
-
Clozapine Treatment in a Patient with a Persistently Low Neutrophil Count
Author(s): James J. Gugger, Charles F. Caley
-
Dual Diagnosis of Substance Abuse and Schizophrenia: Improving Compliance with Pharmacotherapy
Author(s): Samuel Keith
-
Amelioration of Negative Symptoms in Schizophrenia by Escitalopram: A Double-Blind, PlaceboControlled Clinical Trial
Author(s): Saeed Shoja Shafti
-
Cognitive Profile During Remission: Euthymic Bipolar Disorder Patients Compared to Schizophrenia Patients
Author(s): Yoram Braw, Yuval Bloch, Shlomo Mendelovich, Gideon Ratzoni, Hagai Harari, Shmuel Kron, Yechiel Levkovitz